Radioiodine whole body scan pitfalls in differentiated thyroid cancer

C Basso, A Colapinto, V Vicennati, A Gambineri… - Endocrine, 2024 - Springer
Purpose whole body scan (WBS) performed following diagnostic or therapeutic
administration of I-131 is useful in patients with differentiated thyroid carcinoma. However, it …

[HTML][HTML] Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and …

LS Ward, RS Scheffel, AO Hoff, C Ferraz… - … of Endocrinology and …, 2022 - SciELO Brasil
Increasingly sensitive diagnostic methods, better understanding of molecular
pathophysiology, and well-conducted prospective studies have changed the current …

[HTML][HTML] An immediate postoperative response to therapy assessment can help avoid unnecessary RAI therapy

H Zhao, CH Liu, Y Cao, LY Zhang, Y Zhao… - Frontiers in …, 2022 - frontiersin.org
Background Radioiodine (RAI) therapy plays a vital role in the postoperative treatment of
differentiated thyroid cancer (DTC) patients underwent total thyroidectomy (TT). However …

[HTML][HTML] Papillary thyroid microcarcinoma: insights from a cohort of 257 thyroidectomized patients

HC Scherer, PM Fernandes, RS Scheffel… - Hormone and …, 2023 - thieme-connect.com
Papillary thyroid microcarcinoma management evolved, and less aggressive strategies are
now considered. Questions, however, remain on these tumors' behavior, particularly on …

[HTML][HTML] Multifocal Non-Metastatic Radioactive Iodine Avidity on Whole Body Scan after Thyroidectomy for Thyroid Cancer

JTC Chen, K Baweja, L Tse-Agha, S Awad - AACE Clinical Case Reports, 2024 - Elsevier
ABSTRACT Background/Objective Non-metastatic radioactive iodine (RAI) uptake can
complicate the interpretation of whole-body scan (WBS) for differentiated thyroid carcinoma …

Quantitative SPECT and PET Imaging with Iodine Nuclides in Thyroid Cancer

FWT Schoffelen - 2023 - essay.utwente.nl
Iodine dosimetry is becoming increasingly important for the future of radioactive iodine
therapy in refractory thyroid cancer patients and redifferentiation therapies. Personalized …

131I Uptake in a Left Cerebral Infarct on Posttherapy Whole-Body Scan

CWQ Ng, LTJ Cheng, WM Chua… - Clinical Nuclear …, 2022 - journals.lww.com
A 75-year-old woman with papillary thyroid carcinoma who underwent 131 I radioiodine
treatment was incidentally found to have an established left cerebral infarct demonstrating …

[PDF][PDF] Laura Sterian Ward1

RS Scheffel, AO Hoff, C Ferraz, F Vaisman - observatorio.fm.usp.br
Increasingly sensitive diagnostic methods, better understanding of molecular
pathophysiology, and well-conducted prospective studies have changed the current …